Dr. Richard D. David, MD

Dr. David practices at Genesis Healthcare Partners in Sherman Oaks, California.

Dr. David's NPI, 1427158245, was assigned on September 22, 2006. Dr. David graduated from Sidney Kimmel Medical College in 1985. Dr. David holds California license G58038.

Dr. David's primary practice is Genesis Healthcare Partners, at 5522 N Sepulveda Blvd, Sherman Oaks, CA 91411 in Los Angeles County. The practice phone is (760) 436-4558.

Dr. David's primary practice is Genesis Healthcare Partners in Sherman Oaks, California. Dr. David is also affiliated with Torrance Memorial Medical Center. The medical group on file is Unio Specialty Care, Urology, Encinitas (formerly Genesis Healthcare Partners). Dmand AI also links Dr. David to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. David practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. David's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. David is board certified in urology by the American Board of Urology. Dmand AI has Dr. David's licenses on file in 2 states: California and Montana.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, pelvic prolapse and prostate cancer among the conditions Dr. David treats.

CMS data shows 29,704 Medicare services from Dr. David across 40 procedure codes in 2024, for 833 Medicare patients. Medicare paid $487,523 for them.

CMS counts 833 Medicare patients who saw Dr. David in 2024. The largest group is 65 to 74, with 343 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. David's median patient age at 71, with 20% women.

In 2024, Dr. David wrote 2,259 Medicare Part D claims for 495 patients. 81% of them were for generic drugs. CMS names the drug for 2,042 of them, across 33 drugs with 11 or more claims each, at $602,311 in total drug cost. In 2023, CMS named 2,091 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. David for performance year 2024, reported as part of a group. Dr. David accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. David as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. David, published from 2014 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Cystoscopy, Prostatic Hyperplasia and RNA, Messenger. Dr. David's most frequent co-authors are Timothy J. Bradford, MD, Julia A. Bridge, MD and Kevin James Cline, MD.

Dmand AI links Dr. David to 8 clinical trials, 4 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ and Carcinoma, Transitional Cell. CG Oncology, Inc. sponsors the most, 2.

CMS Open Payments shows 1,270 general payments to Dr. David from 75 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 45% of the total. Astellas Pharma US Inc paid the most, $187,582.

Dmand AI lists 2 awards for Dr. David.

Dr. David graduated from Sidney Kimmel Medical College in 1985. Dr. David is a member of ACS and SLS.

Dr. David is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.